SCHEMBL26420682

SCHEMBL26420682

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4ccc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc4)cc4c3oc3cc5ccccc5cc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.34
▸ CSNK2A2 P19784 1/20 0.34
▸ CSNK2B P67870 1/20 0.34
▸ PIM3 Q86V86 1/20 0.34
▸ PIM2 Q9P1W9 1/20 0.34
▸ MAPT P10636 7/20 0.33
▸ KMT2A Q03164 5/20 0.33
▸ TSHR P16473 4/20 0.33
▸ POLB P06746 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ALDH1A1 P00352 7/20 0.32
▸ MEN1 O00255 4/20 0.32
▸ KDM4E B2RXH2 4/20 0.32
▸ HSD17B10 Q99714 4/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ TP53 P04637 2/20 0.32
▸ PLA2G2A P14555 1/20 0.32
▸ PLA2G4A P47712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24586408 0.94 KMT2A (0.36) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24585758 0.92 KMT2A (0.38) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24586404 0.92 ALDH1A1 (0.41) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24066233 0.92 PIM1 (0.34) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24585927 0.91 MAPT (0.35) MAPTKMT2ATSHRPOLBHTT
SCHEMBL24585929 0.91 CYP11B1 (0.35) MAPTKMT2ATSHRPOLBHTT
SCHEMBL24585756 0.89 ALDH1A1 (0.41) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24585757 0.89 ALDH1A1 (0.41) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL26416175 0.89 MAPT (0.33) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24586567 0.89 MAPT (0.36) PIM1CSNK2A2CSNK2BPIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 — — US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 PIM1 1433/4885CSNK2A2 2940/4885CSNK2B 3112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback